Title of article
The benefits of the multi-target approach in drug design and discovery
Author/Authors
L. Michel Espinoza-Fonseca، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
2
From page
896
To page
897
Abstract
Promiscuous binding has been considered to be a problem in the design and development of new drugs against a given disease. However, promiscuity in molecular recognition is not all bad news, and scientists are currently taking advantage of the emerging ‘promiscuous binding’ or ‘multi-target approach’ in medicinal chemistry.
Keywords
Alzheimer’s disease , Promiscuous drug , drug design , Cancer
Journal title
Bioorganic and Medicinal Chemistry
Serial Year
2006
Journal title
Bioorganic and Medicinal Chemistry
Record number
1305470
Link To Document